SCHEMBL5170451

SCHEMBL5170451

CN(C)CC1CCCC(=Cc2ccc(Cl)cc2)C1(O)Cc1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.39
AKR1C3 P42330 2/20 0.37
AKR1C1 Q04828 1/20 0.37
MITF O75030 1/20 0.33
HSP90AA1 P07900 1/20 0.33
OPRM1 P35372 4/20 0.32
OPRD1 P41143 3/20 0.32
OPRK1 P41145 3/20 0.32
SLC6A4 P31645 6/20 0.32
SLC6A2 P23975 5/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
SLC6A3 Q01959 2/20 0.32
SLC22A1 O15245 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
P2RX7 Q99572 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5170480 1.00 CCR6 (0.39) CCR6AKR1C3AKR1C1MITFHSP90AA1
SCHEMBL5168766 0.96 CCR6 (0.36) CCR6AKR1C3AKR1C1OPRM1OPRD1
SCHEMBL5171253 0.96 CCR6 (0.36) CCR6AKR1C3AKR1C1OPRM1OPRD1
SCHEMBL5169364 0.95 CCR6 (0.36) CCR6AKR1C3AKR1C1MITFHSP90AA1
SCHEMBL5169358 0.95 CCR6 (0.36) CCR6AKR1C3AKR1C1MITFHSP90AA1
SCHEMBL5171017 0.95 CCR6 (0.38) CCR6AKR1C3AKR1C1OPRM1OPRD1
SCHEMBL5170684 0.95 CCR6 (0.38) CCR6AKR1C3AKR1C1OPRM1OPRD1
SCHEMBL5170007 0.93 SLC6A4 (0.37) CCR6OPRM1OPRD1OPRK1SLC6A4
SCHEMBL5170001 0.93 SLC6A4 (0.37) CCR6OPRM1OPRD1OPRK1SLC6A4
SCHEMBL5171484 0.91 SMN1; SMN2 (0.38) CCR6AKR1C3AKR1C1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322590-B1 5-AMINO-1-PENTENE-3-OL SUBSTITUTED DERIVATIVES GRUENENTHAL GMBH (DE) 2007-05-02 EP claimed
US-6815443-B2 CARBOCYCLIC OXY AMINES SUCH AS 2-BENZYLIDENE-6-DIMETHYLAMINO METHYLCYCLOHEXANONE, USED AS ANALGESICS GRUENENTHAL GMBH (DE) 2004-11-09 US claimed
US-20030220390-A1 5-Amino-1-pentene-3-ol substituted derivatives GRUENENTHAL GMBH (DE) 2003-11-27 US claimed
EP-1322590-A1 5-AMINO-1-PENTENE-3-OL SUBSTITUTED DERIVATIVES Grünenthal GmbH (DE) 2003-07-02 EP claimed
WO-2002030869-A1 5-AMINO-1-PENTENE-3-OL SUBSTITUTED DERIVATIVES Grünenthal GmbH (DE) 2002-04-18 WO claimed
WO-2002028816-A1 SUBSTITUTED 5-AMINO-1-PENTENE-3-OL DERIVATIVES BUSCHMANN, HELMUT 2002-04-11 WO claimed
EP-1322590-B1 5-AMINO-1-PENTENE-3-OL SUBSTITUTED DERIVATIVES GRUENENTHAL GMBH (DE) 2007-05-02 EP disclosed
US-6815443-B2 CARBOCYCLIC OXY AMINES SUCH AS 2-BENZYLIDENE-6-DIMETHYLAMINO METHYLCYCLOHEXANONE, USED AS ANALGESICS GRUENENTHAL GMBH (DE) 2004-11-09 US disclosed
US-20030220390-A1 5-Amino-1-pentene-3-ol substituted derivatives GRUENENTHAL GMBH (DE) 2003-11-27 US disclosed
WO-2002028816-A1 SUBSTITUTED 5-AMINO-1-PENTENE-3-OL DERIVATIVES BUSCHMANN, HELMUT 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220390-A1 5-Amino-1-pentene-3-ol substituted derivatives ALOX5, PGA5, ANXA5 CCR6 3774/4885AKR1C3 1384/4885AKR1C1 2293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.